Yeast Systematic Name | Yeast Symbol | SGDID | Analog Name | Analog Description | EC | Organism | Disease | Structure | Uniprot | Human ID | Human Symbol | HHsearch Probability | HHsearch E_value | HHsearch P_value | HHsearch Score | Flag Disease related | Flag Homo sapiens | Flag Mus musculus | Flag Danio rerio | Flag Drosophila melanogaster | Flag Caenorhabditis elegans | Flag Arabidopsis thaliana | Flag Escherichia coli |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
YHR030C | SLT2 | SGDID:S000001072 | DYRK3 |
Dual specificity tyrosine-phosphorylation-regulated kinase 3 (EC 2.7.12.1) (Regulatory erythroid kinase) (REDK) |
2.7.12.1 | Homo sapiens | Fungal Meningitis,Neuroaspergillosis,Mental Retardation, Autosomal Dominant 7 |
5y86_a | O43781 | ENSG00000143479 | DYRK3 | 99.30 | 3.70E-16 | 2.90E-20 | 166.00 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YHR030C | SLT2 | SGDID:S000001072 | CDK2 CDKN2 |
Cyclin-dependent kinase 2 (EC 2.7.11.22) (Cell division protein kinase 2) (p33 protein kinase) |
2.7.11.22 | Homo sapiens | Pancreatic Adenocarcinoma,Endometrial Cancer,Smooth Muscle Tumor,Melanoma,Endometrial Hyperplasia,Leukemia, Chronic Myeloid,Leiomyosarcoma,Ocular Cancer,Retinal Cancer,Neuroblastoma,Leukemia, Acute Myeloid,Leukemia, Acute Lymphoblastic,Bladder Cancer,Lung Adenoma,Laryngeal Squamous Cell Carcinoma,Ovarian Cancer,Testicular Cancer,Eye Disease,Uterine Sarcoma,Breast Cancer,Glioblastoma,Squamous Cell Carcinoma, Head And Neck,Colorectal Cancer,Nervous System Cancer,Hepatocellular Carcinoma,Microcephaly,Pheochromocytoma,Skin Carcinoma,Gastric Cancer,Prostate Cancer,Cervical Cancer,Cecal Benign Neoplasm,Retinoblastoma,Sensory System Disease,Trichothiodystrophy 5, Nonphotosensitive,Mantle Cell Lymphoma,Gastrointestinal Stromal Tumor,Cecum Adenoma,Leukemia, Chronic Lymphocytic,Ataxia-Telangiectasia,Melanoma, Cutaneous Malignant 1,Lung Cancer,Pancreatic Cancer |
4i3z_c | P24941 | ENSG00000123374 | CDK2 | 99.40 | 6.00E-17 | 5.00E-21 | 154.30 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YHR030C | SLT2 | SGDID:S000001072 | CRK2 PK5 |
Cell division control protein 2 homolog (EC 2.7.11.22) (EC 2.7.11.23) (PfPK5) |
2.7.11.22,2.7.11.23, | Plasmodium falciparum | 1v0b_a | Q07785 | 99.30 | 1.30E-16 | 1.10E-20 | 151.50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YHR030C | SLT2 | SGDID:S000001072 | CPK4 CDPK4 PF07_0072 |
Calcium-dependent protein kinase 4 (EC 2.7.11.1) |
2.7.11.1 | Plasmodium falciparum | 4rgj_a | Q8IBS5 | 99.20 | 1.70E-15 | 1.40E-19 | 156.30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YHR030C | SLT2 | SGDID:S000001072 | BN1205_040370 TGVEG_207820 |
BN1205_040370 TGVEG_207820 |
2.7.11.24 | Toxoplasma gondii | 3rp9_a | B6KP12 | 99.50 | 1.30E-18 | 1.10E-22 | 178.00 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YHR030C | SLT2 | SGDID:S000001072 | CDK1 CDC2 CDC28A CDKN1 P34CDC2 |
Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (EC 2.7.11.23) (Cell division control protein 2 homolog) (Cell division protein kinase 1) (p34 protein kinase) |
2.7.11.22,2.7.11.23, | Homo sapiens | Bartholin'S Gland Adenocarcinoma,Bone Cancer,Polyploidy,Alzheimer Disease,Retinal Cancer,Neuroblastoma,Leukemia, Acute Myeloid,Hereditary Spastic Paraplegia,Leukemia, Acute Lymphoblastic,Bladder Cancer,Brain Cancer,Ovarian Cancer,Breast Cancer,Colorectal Cancer,Hepatocellular Carcinoma,Western Equine Encephalitis,Rhabdomyosarcoma,Fanconi Anemia, Complementation Group A,Neuronal Ceroid Lipofuscinosis,Breast Adenocarcinoma,Prostate Cancer,Cervical Cancer,Retinoblastoma,Lymphoma, Non-Hodgkin, Familial,Esophageal Cancer,Seckel Syndrome,Trichothiodystrophy 5, Nonphotosensitive,Mantle Cell Lymphoma,Gastrointestinal Stromal Tumor,Acute Promyelocytic Leukemia,Leukemia, Chronic Lymphocytic,Ceroid Lipofuscinosis, Neuronal, 2,Bloom Syndrome,Primary Autosomal Recessive Microcephaly,Ceroid Lipofuscinosis, Neuronal, 1,Lung Cancer,Frontotemporal Dementia |
4yc3_a | P06493 | ENSG00000170312 | CDK1 | 99.40 | 4.50E-17 | 3.80E-21 | 156.00 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YHR030C | SLT2 | SGDID:S000001072 | CDK7 CAK CAK1 CDKN7 MO15 STK1 |
Cyclin-dependent kinase 7 (EC 2.7.11.22) (EC 2.7.11.23) (39 kDa protein kinase) (p39 Mo15) (CDK-activating kinase 1) (Cell division protein kinase 7) (Serine/threonine-protein kinase 1) (TFIIH basal transcription factor complex kinase subunit) |
2.7.11.22,2.7.11.23, | Homo sapiens | Myofibrillar Myopathy,Cockayne Syndrome,Breast Cancer,Xeroderma Pigmentosum, Complementation Group D,Xeroderma Pigmentosum, Variant Type,Xeroderma Pigmentosum, Complementation Group B |
1ua2_b | P50613 | ENSG00000134058 | CDK7 | 99.40 | 1.30E-17 | 1.10E-21 | 163.70 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YHR030C | SLT2 | SGDID:S000001072 | MAPK6 ERK3 PRKM6 |
Mitogen-activated protein kinase 6 (MAP kinase 6) (MAPK 6) (EC 2.7.11.24) (Extracellular signal-regulated kinase 3) (ERK-3) (MAP kinase isoform p97) (p97-MAPK) |
2.7.11.24 | Homo sapiens | Pulmonary Immaturity,Aromatase Excess Syndrome |
2i6l_a | Q16659 | ENSG00000069956 | MAPK6 | 99.30 | 4.30E-16 | 3.60E-20 | 150.00 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YHR030C | SLT2 | SGDID:S000001072 | MASTL GW GWL THC2 |
Serine/threonine-protein kinase greatwall (GW) (GWL) (hGWL) (EC 2.7.11.1) (Microtubule-associated serine/threonine-protein kinase-like) (MAST-L) |
2.7.11.1 | Homo sapiens | Autosomal Thrombocytopenia With Normal Platelets,Sick Building Syndrome,Thrombocytopenia,Thrombocytopenia 2,Gray Platelet Syndrome,Ceroid Lipofuscinosis, Neuronal, 2 |
5loh_a | Q96GX5 | ENSG00000120539 | MASTL | 99.20 | 1.50E-15 | 1.30E-19 | 149.00 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YHR030C | SLT2 | SGDID:S000001072 | MAPK13 PRKM13 SAPK4 |
Mitogen-activated protein kinase 13 (MAP kinase 13) (MAPK 13) (EC 2.7.11.24) (Mitogen-activated protein kinase p38 delta) (MAP kinase p38 delta) (Stress-activated protein kinase 4) |
2.7.11.24 | Homo sapiens | 3coi_a | O15264 | ENSG00000156711 | MAPK13 | 99.50 | 4.80E-19 | 3.90E-23 | 175.00 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YHR030C | SLT2 | SGDID:S000001072 | CSNK2A2 CK2A2 |
Casein kinase II subunit alpha' (CK II alpha') (EC 2.7.11.1) |
2.7.11.1 | Homo sapiens | Connective Tissue Disease,Neonatal Leukemia,Distal Muscular Dystrophy With Anterior Tibial Onset,Spermatogenic Failure 50,Breast Adenocarcinoma,Theileriasis,Spermatogenic Failure 9 |
6hmq_a | P19784 | ENSG00000070770 | CSNK2A2 | 99.30 | 5.80E-16 | 4.70E-20 | 153.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YHR030C | SLT2 | SGDID:S000001072 | CDK16 PCTAIRE1 PCTK1 |
Cyclin-dependent kinase 16 (EC 2.7.11.22) (Cell division protein kinase 16) (PCTAIRE-motif protein kinase 1) (Serine/threonine-protein kinase PCTAIRE-1) |
2.7.11.22 | Homo sapiens | 5g6v_a | Q00536 | ENSG00000102225 | CDK16 | 99.40 | 4.60E-17 | 3.80E-21 | 158.80 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YHR030C | SLT2 | SGDID:S000001072 | Brsk2 Kiaa4256 Sada |
Serine/threonine-protein kinase BRSK2 (EC 2.7.11.1) (EC 2.7.11.26) (Brain-specific serine/threonine-protein kinase 2) (BR serine/threonine-protein kinase 2) (Serine/threonine-protein kinase SAD-A) |
2.7.11.26 | Mus musculus | 4ynz_b | Q69Z98 | 99.30 | 2.60E-16 | 2.20E-20 | 154.40 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | |||
YHR030C | SLT2 | SGDID:S000001072 | cgd4_240 |
cgd4_240 |
Cryptosporidium parvum | 3eb0_a | A3FQN0 | 99.30 | 3.30E-16 | 2.70E-20 | 156.50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YHR030C | SLT2 | SGDID:S000001072 | CHEK2 CDS1 CHK2 RAD53 |
Serine/threonine-protein kinase Chk2 (EC 2.7.11.1) (CHK2 checkpoint homolog) (Cds1 homolog) (Hucds1) (hCds1) (Checkpoint kinase 2) |
2.7.11.1 | Homo sapiens | Squamous Cell Carcinoma,Cerebral Hemisphere Lipoma,Corpus Callosum Lipoma,Adenoid Cystic Carcinoma,Cowden Syndrome,Cervical Adenoma Malignum,Leiomyosarcoma,Bilateral Breast Cancer,B-Lymphoblastic Leukemia/Lymphoma,Diffuse Midline Glioma, H3 K27m-Mutant,Essential Thrombocythemia,Congenital Heart Defects, Multiple Types, 3,Familial Colorectal Cancer,Leukemia,Inherited Cancer-Predisposing Syndrome,Wilms Tumor 5,Leukemia, Acute Myeloid,Sporadic Breast Cancer,Li-Fraumeni Syndrome 1,Telangiectasis,Basal Cell Carcinoma,Lung Leiomyosarcoma,Prostate Leiomyosarcoma,Cerebellar Disease,Bile Duct Cystadenoma,T-Cell Prolymphocytic Leukemia,Nk-Cell Enteropathy,Ovarian Cancer,Breast Cancer,Hereditary Breast Ovarian Cancer Syndrome,Colorectal Cancer,Li-Fraumeni Syndrome 2,Premature Menopause,Rhabdomyosarcoma,Xeroderma Pigmentosum, Variant Type,Sarcoma,Fanconi Anemia, Complementation Group A,Bone Osteosarcoma,Skin Carcinoma,Gastric Cancer,Breast Adenocarcinoma,Prostate Cancer,Thrombocytopenia,Lynch Syndrome,Esophageal Cancer,Seckel Syndrome,Myelodysplastic Syndrome,Gastric Cancer, Hereditary Diffuse,Tumor Predisposition Syndrome,Cutaneous Telangiectasia And Cancer Syndrome, Familial,Wilms Tumor 1,Autosomal Recessive Cerebellar Ataxia,Lymphoma,Nijmegen Breakage Syndrome,Colitis,Li-Fraumeni Syndrome,Premature Ovarian Failure 1,Ataxia-Telangiectasia,Melanoma, Cutaneous Malignant 1,Lung Cancer,Osteogenic Sarcoma |
3i6u_a | O96017 | ENSG00000183765 | CHEK2 | 99.20 | 1.50E-15 | 1.30E-19 | 153.70 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YHR030C | SLT2 | SGDID:S000001072 | MAPK9 JNK2 PRKM9 SAPK1A |
Mitogen-activated protein kinase 9 (MAP kinase 9) (MAPK 9) (EC 2.7.11.24) (JNK-55) (Stress-activated protein kinase 1a) (SAPK1a) (Stress-activated protein kinase JNK2) (c-Jun N-terminal kinase 2) |
2.7.11.24 | Homo sapiens | Leukemia, Chronic Myeloid,Diabetes Mellitus,Alzheimer Disease,Nephronophthisis,Breast Cancer,Colorectal Cancer,Pheochromocytoma,Skin Carcinoma,Cardiomyopathy, Familial Hypertrophic, 25 |
3npc_a | P45984 | ENSG00000050748 | MAPK9 | 99.30 | 5.90E-16 | 4.80E-20 | 153.60 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YHR030C | SLT2 | SGDID:S000001072 | RPS6KA1 MAPKAPK1A RSK1 |
Ribosomal protein S6 kinase alpha-1 (S6K-alpha-1) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 1) (p90-RSK 1) (p90RSK1) (p90S6K) (MAP kinase-activated protein kinase 1a) (MAPK-activated protein kinase 1a) (MAPKAP kinase 1a) (MAPKAPK-1a) (Ribosomal S6 kinase 1) (RSK-1) |
2.7.11.1 | Homo sapiens | Tuberous Sclerosis 2,Tuberous Sclerosis,Cardiomyopathy, Familial Hypertrophic, 4,Disease Of Mental Health,Adrenal Cortical Adenocarcinoma,Dyskeratosis Congenita, Autosomal Dominant 3,Tuberous Sclerosis 1,Coffin-Lowry Syndrome,Polycystic Kidney Disease 3 With Or Without Polycystic Liver Disease |
4nif_d | Q15418 | ENSG00000117676 | RPS6KA1 | 99.20 | 1.40E-15 | 1.20E-19 | 148.60 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YHR030C | SLT2 | SGDID:S000001072 | CDKL2 |
Cyclin-dependent kinase-like 2 (EC 2.7.11.22) (Protein kinase p56 KKIAMRE) (Serine/threonine-protein kinase KKIAMRE) |
2.7.11.22 | Homo sapiens | Papillary Serous Adenocarcinoma,Orofaciodigital Syndrome Vi |
4aaa_a | Q92772 | ENSG00000138769 | CDKL2 | 99.40 | 4.40E-17 | 3.60E-21 | 159.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YHR030C | SLT2 | SGDID:S000001072 | MGG_04943 |
MGG_04943 |
2.7.11.24 | Magnaporthe oryzae | 5z33_a | G4N374 | 99.70 | 1.50E-22 | 1.20E-26 | 207.00 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YHR030C | SLT2 | SGDID:S000001072 | FUS3 DAC2 YBL016W YBL03.21 YBL0303 |
Mitogen-activated protein kinase FUS3 (MAP kinase FUS3) (EC 2.7.11.24) |
2.7.11.24 | Saccharomyces cerevisiae | 2b9h_a | P16892 | 99.30 | 3.30E-16 | 2.80E-20 | 154.30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YHR030C | SLT2 | SGDID:S000001072 | CDKL1 |
Cyclin-dependent kinase-like 1 (EC 2.7.11.22) (Protein kinase p42 KKIALRE) (Serine/threonine-protein kinase KKIALRE) |
2.7.11.22 | Homo sapiens | Fraser Syndrome 1 |
4agu_b | Q00532 | ENSG00000100490 | CDKL1 | 99.30 | 2.10E-16 | 1.80E-20 | 152.10 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YHR030C | SLT2 | SGDID:S000001072 | LMJF_10_0200 |
LMJF_10_0200 |
Leishmania major | 3pg1_a | Q4QHJ8 | 99.50 | 4.20E-18 | 3.40E-22 | 168.80 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YHR030C | SLT2 | SGDID:S000001072 | Camk1 |
Calcium/calmodulin-dependent protein kinase type 1 (EC 2.7.11.17) (CaM kinase I) (CaM-KI) (CaM kinase I alpha) (CaMKI-alpha) |
2.7.11.17 | Rattus norvegicus | 1a06_a | Q63450 | 99.80 | 4.80E-25 | 3.70E-29 | 216.80 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YHR030C | SLT2 | SGDID:S000001072 | CDKL5 STK9 |
Cyclin-dependent kinase-like 5 (EC 2.7.11.22) (Serine/threonine-protein kinase 9) |
2.7.11.22 | Homo sapiens | Cdkl5 Deficiency Disorder,Ohtahara Syndrome,Seizure Disorder,Childhood Absence Epilepsy,Epilepsy,Gait Apraxia,Gene Duplication Disease,Nicolaides-Baraitser Syndrome,Amyotrophic Lateral Sclerosis 1,Angelman Syndrome,Focal Epilepsy,Developmental And Epileptic Encephalopathy 14,Epilepsy With Generalized Tonic-Clonic Seizures,Congenital Nervous System Abnormality,Developmental And Epileptic Encephalopathy,Fundus Dystrophy,Juvenile Retinoschisis,Bruxism,X-Linked Congenital Retinoschisis,Early Myoclonic Encephalopathy,Stxbp1 Encephalopathy,Microcephaly,Mental Retardation, Autosomal Dominant 20,Encephalopathy,Benign Neonatal Seizures,Alacrima, Achalasia, And Mental Retardation Syndrome,Benign Epilepsy With Centrotemporal Spikes,Developmental And Epileptic Encephalopathy 9,Methylmalonic Acidemia,Benign Familial Neonatal Epilepsy,West Syndrome,Disease Of Mental Health,Lubs X-Linked Mental Retardation Syndrome,Fragile X Syndrome,Pitt-Hopkins Syndrome,Mowat-Wilson Syndrome,Developmental And Epileptic Encephalopathy 2,Lennox-Gastaut Syndrome,Sturge-Weber Syndrome,Neonatal Period Electroclinical Syndrome,Infancy Electroclinical Syndrome,Childhood Electroclinical Syndrome,Early Infantile Epileptic Encephalopathy,Developmental And Epileptic Encephalopathy 4,Myasthenic Syndrome, Congenital, 11, Associated With Acetylcholine Receptor Deficiency,Encephalopathy Due To Defective Mitochondrial And Peroxisomal Fission 1,Aicardi Syndrome,Specific Developmental Disorder,Pervasive Developmental Disorder,Dravet Syndrome,Developmental And Epileptic Encephalopathy 1,Benign Familial Infantile Epilepsy,Generalized Epilepsy With Febrile Seizures Plus,Pyruvate Dehydrogenase E1-Alpha Deficiency,Retinoschisis 1, X-Linked, Juvenile,Rett Syndrome,Epilepsy, Myoclonic Juvenile,Autism,Christianson Syndrome,Epilepsy, Idiopathic Generalized,Peho Syndrome |
4bgq_a | O76039 | ENSG00000008086 | CDKL5 | 99.40 | 4.40E-17 | 3.70E-21 | 155.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YHR030C | SLT2 | SGDID:S000001072 | ACK2 |
Casein kinase II subunit alpha (EC 2.7.11.1) (CK II) (CK2-alpha) |
2.7.11.1 | Zea mays | 4dgn_a | P28523 | 99.30 | 5.00E-16 | 4.20E-20 | 150.60 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YHR030C | SLT2 | SGDID:S000001072 | CDK13 CDC2L CDC2L5 CHED KIAA1791 |
Cyclin-dependent kinase 13 (EC 2.7.11.22) (EC 2.7.11.23) (CDC2-related protein kinase 5) (Cell division cycle 2-like protein kinase 5) (Cell division protein kinase 13) (hCDK13) (Cholinesterase-related cell division controller) |
2.7.11.22,2.7.11.23, | Homo sapiens | Corneal Endothelial Dystrophy,Neuroblastoma,Congenital Heart Defects, Dysmorphic Facial Features, And Intellectual Developmental Disorder,Microcephaly,Corneal Dystrophy, Posterior Polymorphous, 1,Spinocerebellar Ataxia 14,Strabismus,White-Sutton Syndrome |
5efq_a | Q14004 | ENSG00000065883 | CDK13 | 99.20 | 1.20E-15 | 9.60E-20 | 149.80 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YHR030C | SLT2 | SGDID:S000001072 | TTN |
Titin (EC 2.7.11.1) (Connectin) (Rhabdomyosarcoma antigen MU-RMS-40.14) |
2.7.11.1 | Homo sapiens | Muscular Disease,Heart Disease,Constrictive Pericarditis,Congenital Fiber-Type Disproportion,Mitral Valve Insufficiency,Aortic Valve Disease 2,Congenital Structural Myopathy,Myopathy,Amyloidosis,Cardiomyopathy, Dilated, 1e,Syncope,Myofibrillar Myopathy,Atrial Heart Septal Defect,Mitochondrial Dna Depletion Syndrome 12b,Childhood-Onset Progressive Contractures-Limb-Girdle Weakness-Muscle Dystrophy Syndrome,Emery-Dreifuss Muscular Dystrophy,Cortical Thymoma,Muscle Tissue Disease,Morvan'S Fibrillary Chorea,Neuromuscular Disease,Hypertrophic Cardiomyopathy,Familial Isolated Dilated Cardiomyopathy,Rasopathy,Autosomal Dominant Distal Myopathy,Lung Large Cell Carcinoma,Myopathy, Distal, 1,Myositis,Myotonic Dystrophy 1,Systolic Heart Failure,Myopathy, Myofibrillar, 1,Diastolic Heart Failure,Autosomal Recessive Limb-Girdle Muscular Dystrophy,Autosomal Recessive Limb-Girdle Muscular Dystrophy Type 2a,Muscular Dystrophy,Autosomal Recessive Limb-Girdle Muscular Dystrophy Type 2g,Autosomal Recessive Limb-Girdle Muscular Dystrophy Type 2j,Muscular Atrophy,Tibial Muscular Dystrophy,Limb-Girdle Muscular Dystrophy,Arrhythmogenic Right Ventricular Dysplasia, Familial, 1,Epithelial Malignant Thymoma,Hyaline Body Myopathy,Isolated Elevated Serum Creatine Phosphokinase Levels,Noonan Syndrome 1,Newborn Respiratory Distress Syndrome,Thymus Clear Cell Carcinoma,Reducing Body Myopathy,Myocarditis,Atrial Standstill 1,Muscular Dystrophy, Limb-Girdle, Autosomal Recessive 10,Hereditary Proximal Myopathy With Early Respiratory Failure,Dilated Cardiomyopathy,Alcoholic Cardiomyopathy,Lmna-Related Dilated Cardiomyopathy,Thymus Gland Disease,Long Qt Syndrome,Cardiomyopathy, Dilated, 1dd,Heart Conduction Disease,Udd Distal Myopathy - Tibial Muscular Dystrophy,Muscular Dystrophy, Congenital, Lmna-Related,Neuropathy,Perinephritis,Familial Isolated Arrhythmogenic Ventricular Dysplasia, Right Dominant Form,Familial Isolated Arrhythmogenic Ventricular Dysplasia, Biventricular Form,Familial Isolated Arrhythmogenic Ventricular Dysplasia, Left Dominant Form,Myopathy, Myofibrillar, 3,Sick Sinus Syndrome,Multiminicore Disease,Cardiomyopathy, Familial Hypertrophic, 4,Cardiomyopathy, Dilated, 1a,Congestive Heart Failure,Myopathy, Myofibrillar, 4,Left Ventricular Noncompaction 2,Foot Drop,Myopathy, Myofibrillar, 5,Rhabdomyosarcoma,Rigid Spine Muscular Dystrophy 1,Epidermolysis Bullosa Simplex With Muscular Dystrophy,Thymoma,Thymus Cancer,Dendritic Cell Thymoma,Respiratory Failure,Centronuclear Myopathy,Myopathy, Myofibrillar, 9, With Early Respiratory Failure,Cardiomyopathy, Dilated, 1g,Congenital Myasthenic Syndrome,Cardiomyopathy, Familial Hypertrophic, 9,Cardiomyopathy, Dilated, 1h,Orthostatic Intolerance,Emery-Dreifuss Muscular Dystrophy 2, Autosomal Dominant,Lung Squamous Cell Carcinoma,Restrictive Cardiomyopathy,Extrinsic Cardiomyopathy,Lambert-Eaton Myasthenic Syndrome,Arrhythmogenic Right Ventricular Cardiomyopathy,Brugada Syndrome,Muscle Hypertrophy,Salih Myopathy,Nonaka Myopathy,Primary Cutaneous Amyloidosis,Distal Arthrogryposis,Familial Atrial Fibrillation,Hypermethioninemia Due To Adenosine Kinase Deficiency,Atrioventricular Block,Third-Degree Atrioventricular Block,Barth Syndrome,Cardioneuromyopathy With Hyaline Masses And Nemaline Rods,Cardiomyopathy, Familial Hypertrophic, 1,Wolff-Parkinson-White Syndrome,Muscular Dystrophy-Dystroglycanopathy , Type C, 5,Intrinsic Cardiomyopathy,Peripartum Cardiomyopathy,Lipoprotein Quantitative Trait Locus,Atrial Fibrillation,Scoliosis,Muscular Dystrophy, Duchenne Type,Myopathy, Centronuclear, X-Linked,Cardiac Arrest,Inguinal Hernia,Muscular Dystrophy, Limb-Girdle, Autosomal Recessive 2,Myasthenia Gravis,Left Ventricular Noncompaction,Lethal Congenital Contracture Syndrome,Myopathy, Centronuclear, 2,Batten-Turner Congenital Myopathy,Miyoshi Muscular Dystrophy,Tibial Muscular Dystrophy, Tardive,Cardiomyopathy, Dilated, 1b |
1tki_b | Q8WZ42 | ENSG00000155657 | TTN | 99.20 | 1.20E-15 | 1.00E-19 | 148.00 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YHR030C | SLT2 | SGDID:S000001072 | PTSG_10090 |
PTSG_10090 |
2.7.11.17 | Salpingoeca rosetta | 5ig1_b | F2UPG5 | 99.30 | 2.20E-16 | 1.80E-20 | 155.40 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YHR030C | SLT2 | SGDID:S000001072 | CDK4 |
Cyclin-dependent kinase 4 (EC 2.7.11.22) (Cell division protein kinase 4) (PSK-J3) |
2.7.11.22 | Homo sapiens | Melanoma In Congenital Melanocytic Nevus,Pancreatic Adenocarcinoma,Skin Melanoma,Endometrial Cancer,Malignant Inflammatory Fibrous Histiocytoma,Childhood Acute Lymphocytic Leukemia,Retinitis Pigmentosa,Pancreas Sarcoma,Lung Cancer Susceptibility 3,Chondrosarcoma,Myofibrillar Myopathy,Rhabdomyosarcoma 2,Malignant Fibrous Histiocytoma,Melanoma,Plasma Cell Neoplasm,Dedifferentiated Liposarcoma,Myxofibrosarcoma,Myositis Ossificans,Leiomyosarcoma,Connective Tissue Cancer,Bone Sarcoma,Undifferentiated Embryonal Sarcoma Of The Liver,Infiltrating Lipoma,Large Cell Carcinoma,Ischemic Fasciitis,B-Cell Lymphoma,T-Cell Lymphoblastic Leukemia/Lymphoma,Ocular Cancer,Retinal Cancer,Familial Retinoblastoma,Embryonal Sarcoma,Retroperitoneal Sarcoma,Retroperitoneum Carcinoma,Neuroblastoma,Pilocytic Astrocytoma,Inherited Cancer-Predisposing Syndrome,Glioma,Leukemia, Acute Myeloid,Leukemia, Acute Lymphoblastic,Hereditary Melanoma,Ring Chromosome 7,Nodular Malignant Melanoma,Bladder Cancer,Spindle Cell Lipoma,Pleomorphic Lipoma,Lipoma Of Spermatic Cord,Paratesticular Lipoma,Melanoma, Cutaneous Malignant 3,Ring Chromosome,Lipoblastoma,Ovarian Cancer,Myeloid Leukemia,Burkitt Lymphoma,Adenocarcinoma,Testicular Cancer,T-Cell Acute Lymphoblastic Leukemia,Eye Disease,Breast Cancer,Glioblastoma,Squamous Cell Carcinoma, Head And Neck,Well-Differentiated Liposarcoma,Malignant Astrocytoma,Cellular Myxoid Liposarcoma,High Grade Glioma,Adult Liposarcoma,Pediatric Liposarcoma,Gliosarcoma,Gastric Liposarcoma,Breast Liposarcoma,Pleomorphic Liposarcoma,Mixed Liposarcoma,Spindle Cell Liposarcoma,Mediastinum Liposarcoma,Anaplastic Astrocytoma,Colorectal Cancer,Peripheral Nervous System Disease,Nervous System Cancer,Hepatocellular Carcinoma,Oligodendroglioma,Malignant Peripheral Nerve Sheath Tumor,Pheochromocytoma,Embryonal Rhabdomyosarcoma,Rhabdomyosarcoma,Myxoid Liposarcoma,Sarcoma,Extraosseous Osteosarcoma,Juxtacortical Osteosarcoma,Peripheral Osteosarcoma,Bone Osteosarcoma,Conventional Central Osteosarcoma,Liposarcoma Of Bone,Liposarcoma,Skin Carcinoma,Gastric Cancer,Breast Adenocarcinoma,Prostate Cancer,Infiltrating Angiolipoma,Thrombocytopenia,Retinoblastoma,Type 2 Diabetes Mellitus,Lung Squamous Cell Carcinoma,Diffuse Lipomatosis,Sensory System Disease,Muscle Cancer,Esophageal Cancer,Tumor Predisposition Syndrome,Diffuse Large B-Cell Lymphoma,Ewing Sarcoma,Mantle Cell Lymphoma,Acute Promyelocytic Leukemia,Inflammatory Myofibroblastic Tumor,Cutaneous Telangiectasia And Cancer Syndrome, Familial,Nasopharyngeal Carcinoma,Lymphoma,Connective Tissue Benign Neoplasm,Kaposi Sarcoma,Leukemia, Chronic Lymphocytic,Li-Fraumeni Syndrome,Lipomatosis, Multiple,Dermatofibrosarcoma Protuberans,Parameningeal Embryonal Rhabdomyosarcoma,Myeloma, Multiple,Medulloblastoma,Melanoma, Cutaneous Malignant 1,Melanoma, Uveal,Neu-Laxova Syndrome 1,Lung Cancer,Osteogenic Sarcoma,Pancreatic Cancer |
2w99_b | P11802 | ENSG00000135446 | CDK4 | 99.30 | 2.90E-16 | 2.50E-20 | 150.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YHR030C | SLT2 | SGDID:S000001072 | PRKAA2 AMPK AMPK2 |
5'-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK subunit alpha-2) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) |
2.7.11.27,2.7.11.31, | Homo sapiens | Hyperglycemia,Hypertrophic Cardiomyopathy,Glycogen Storage Disease,Phosphorylase Kinase Deficiency,Tuberous Sclerosis,Breast Cancer,Ischemia,Aromatase Deficiency,Peutz-Jeghers Syndrome,Body Mass Index Quantitative Trait Locus 11,Type 2 Diabetes Mellitus,Wolff-Parkinson-White Syndrome |
2h6d_a | P54646 | ENSG00000162409 | PRKAA2 | 99.20 | 1.00E-15 | 8.40E-20 | 144.10 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YHR030C | SLT2 | SGDID:S000001072 | SRK2I 41K OSKL2 SNRK2.3 At5g66880 MUD21.14 |
Serine/threonine-protein kinase SRK2I (EC 2.7.11.1) (OST1-kinase-like 2) (Protein ATHPROKIN B) (SNF1-related kinase 2.3) (SnRK2.3) |
2.7.11.1 | Arabidopsis thaliana | 3uc3_a | Q39193 | 99.30 | 4.80E-16 | 4.00E-20 | 153.50 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | |||
YHR030C | SLT2 | SGDID:S000001072 | unc-43 K11E8.1 |
Calcium/calmodulin-dependent protein kinase type II (CaM kinase II) (EC 2.7.11.17) (Uncoordinated protein 43) |
2.7.11.17 | Caenorhabditis elegans | 2bdw_b | O62305 | 99.30 | 5.10E-16 | 4.20E-20 | 153.80 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | |||
YHR030C | SLT2 | SGDID:S000001072 | MARK3 CTAK1 EMK2 |
MAP/microtubule affinity-regulating kinase 3 (EC 2.7.11.1) (C-TAK1) (cTAK1) (Cdc25C-associated protein kinase 1) (ELKL motif kinase 2) (EMK-2) (Protein kinase STK10) (Ser/Thr protein kinase PAR-1) (Par-1a) (Serine/threonine-protein kinase p78) |
2.7.11.1 | Homo sapiens | Focal Epithelial Hyperplasia,Osteoporosis,Peutz-Jeghers Syndrome,Gaucher Disease, Type Iii,Visual Impairment And Progressive Phthisis Bulbi |
2qnj_b | P27448 | ENSG00000075413 | MARK3 | 99.30 | 4.80E-16 | 4.00E-20 | 151.10 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YHR030C | SLT2 | SGDID:S000001072 | MAPK7 BMK1 ERK5 PRKM7 |
Mitogen-activated protein kinase 7 (MAP kinase 7) (MAPK 7) (EC 2.7.11.24) (Big MAP kinase 1) (BMK-1) (Extracellular signal-regulated kinase 5) (ERK-5) |
2.7.11.24 | Homo sapiens | Bone Cancer,Noma,Primary Bone Cancer,Dilated Cardiomyopathy,Breast Cancer,Prostate Cancer,Osteogenesis Imperfecta, Type Xviii,Scoliosis, Isolated 1,Scoliosis |
4zsg_a | Q13164 | ENSG00000166484 | MAPK7 | 99.70 | 2.00E-22 | 1.70E-26 | 198.80 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YHR030C | SLT2 | SGDID:S000001072 | MAP4K3 RAB8IPL1 |
Mitogen-activated protein kinase kinase kinase kinase 3 (EC 2.7.11.1) (Germinal center kinase-related protein kinase) (GLK) (MAPK/ERK kinase kinase kinase 3) (MEK kinase kinase 3) (MEKKK 3) |
2.7.11.1 | Homo sapiens | Adult-Onset Still'S Disease |
5j5t_a | Q8IVH8 | ENSG00000011566 | MAP4K3 | 99.30 | 3.20E-16 | 2.70E-20 | 155.60 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YHR030C | SLT2 | SGDID:S000001072 | LDBPK_100540 |
LDBPK_100540 |
2.7.11.24 | Leishmania donovani | 4o2z_a | E9BA99 | 99.40 | 7.00E-17 | 5.70E-21 | 161.40 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YHR030C | SLT2 | SGDID:S000001072 | SNF1 CAT1 CCR1 GLC2 PAS14 YDR477W D8035.20 |
Carbon catabolite-derepressing protein kinase (EC 2.7.11.1) (Sucrose nonfermentating protein 1) |
2.7.11.1 | Saccharomyces cerevisiae | 2fh9_a | P06782 | 99.20 | 1.20E-15 | 9.90E-20 | 143.60 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YHR030C | SLT2 | SGDID:S000001072 | CDK9 CDC2L4 TAK |
Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (C-2K) (Cell division cycle 2-like protein kinase 4) (Cell division protein kinase 9) (Serine/threonine-protein kinase PITALRE) (Tat-associated kinase complex catalytic subunit) |
2.7.11.22,2.7.11.23, | Homo sapiens | Leukemia, Acute Myeloid,Human Immunodeficiency Virus Type 1,Immune Deficiency Disease,Leukemia, Chronic Lymphocytic,Nut Midline Carcinoma |
3mi9_a | P50750 | ENSG00000136807 | CDK9 | 99.30 | 2.50E-16 | 2.10E-20 | 155.00 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YHR030C | SLT2 | SGDID:S000001072 | ROCK2 |
Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2) |
2.7.11.1 | Bos taurus | 2f2u_b | Q28021 | 99.20 | 1.00E-15 | 8.20E-20 | 154.00 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YHR030C | SLT2 | SGDID:S000001072 | PKMYT1 MYT1 |
Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase (EC 2.7.11.1) (Myt1 kinase) |
2.7.11.1 | Homo sapiens | 5vcy_a | Q99640 | ENSG00000127564 | PKMYT1 | 99.30 | 4.40E-16 | 3.70E-20 | 149.80 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YHR030C | SLT2 | SGDID:S000001072 | ROP8 |
ROP8 |
Toxoplasma gondii | 3byv_a | O15693 | 99.30 | 6.40E-16 | 5.20E-20 | 153.80 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YHR030C | SLT2 | SGDID:S000001072 | RAD53 MEC2 SAD1 SPK1 YPL153C P2588 |
Serine/threonine-protein kinase RAD53 (EC 2.7.12.1) (CHEK2 homolog) (Serine-protein kinase 1) |
2.7.12.1 | Saccharomyces cerevisiae | 4pdp_a | P22216 | 99.30 | 5.70E-16 | 4.70E-20 | 152.10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YHR030C | SLT2 | SGDID:S000001072 | Rop2 |
Rop2 |
Toxoplasma gondii | 3dzo_a | Q06AK3 | 99.20 | 8.80E-16 | 7.20E-20 | 155.10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YHR030C | SLT2 | SGDID:S000001072 | STRADA LYK5 STRAD |
STE20-related kinase adapter protein alpha (STRAD alpha) (STE20-related adapter protein) (Serologically defined breast cancer antigen NY-BR-96) |
Homo sapiens | Epilepsy,Polyhydramnios,Endometrial Squamous Cell Carcinoma,Breast Cancer,Megalencephaly,Benign Epilepsy With Centrotemporal Spikes,Scheuermann Disease,Polyhydramnios, Megalencephaly, And Symptomatic Epilepsy |
2wtk_b | Q7RTN6 | ENSG00000266173 | STRADA | 99.30 | 5.00E-16 | 4.10E-20 | 154.20 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YHR030C | SLT2 | SGDID:S000001072 | GL50803_008037 GL50803_8037 |
GL50803_008037 GL50803_8037 |
Giardia intestinalis | 3gbz_a | A8BZ95 | 99.30 | 4.90E-16 | 4.10E-20 | 151.20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YHR030C | SLT2 | SGDID:S000001072 | PHKG1 PHKG |
Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform (EC 2.7.11.19) (Phosphorylase kinase subunit gamma-1) (Serine/threonine-protein kinase PHKG1) (EC 2.7.11.1) (EC 2.7.11.26) |
2.7.11.1,2.7.11.19,2.7.11.26 | Oryctolagus cuniculus | 2phk_a | P00518 | 99.20 | 6.50E-16 | 5.50E-20 | 144.90 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YHR030C | SLT2 | SGDID:S000001072 | GSK3B |
Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1) |
2.7.11.26 | Homo sapiens | Liver Disease,Endometrial Cancer,Epilepsy,Polycystic Kidney Disease,Diabetes Mellitus,Alzheimer Disease,Major Depressive Disorder,Neuroblastoma,Cervical Non-Keratinizing Squamous Cell Carcinoma,Barbiturate Dependence,Alzheimer Disease 9,Dementia,Fallopian Tube Serous Adenocarcinoma,Breast Cancer,Parkinson Disease, Late-Onset,Colorectal Cancer,Parkinson Disease 1, Autosomal Dominant,Hepatocellular Carcinoma,Bipolar Disorder,Gastric Cancer,Prostate Cancer,Disease Of Mental Health,Type 2 Diabetes Mellitus,Schizophrenia,Ophthalmomyiasis,Familial Adenomatous Polyposis,Severe Congenital Neutropenia,Aneurysmal Bone Cysts,Attention Deficit-Hyperactivity Disorder,Medulloblastoma,Frontotemporal Dementia,Pancreatic Cancer |
1h8f_a | P49841 | ENSG00000082701 | GSK3B | 99.30 | 2.90E-16 | 2.40E-20 | 154.70 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YHR030C | SLT2 | SGDID:S000001072 | MAPK14 CSBP CSBP1 CSBP2 CSPB1 MXI2 SAPK2A |
Mitogen-activated protein kinase 14 (MAP kinase 14) (MAPK 14) (EC 2.7.11.24) (Cytokine suppressive anti-inflammatory drug-binding protein) (CSAID-binding protein) (CSBP) (MAP kinase MXI2) (MAX-interacting protein 2) (Mitogen-activated protein kinase p38 alpha) (MAP kinase p38 alpha) (Stress-activated protein kinase 2a) (SAPK2a) |
2.7.11.24 | Homo sapiens | Psoriasis,Heart Disease,Bladder Lateral Wall Cancer,Leukemia, Chronic Myeloid,Gaucher'S Disease,Alzheimer Disease,Myocardial Infarction,Doxorubicin Induced Cardiomyopathy,Human Cytomegalovirus Infection,Vitreous Abscess,Anthrax Disease,Colon Adenocarcinoma,Autoimmune Disease,Dilated Cardiomyopathy,Ureteral Obstruction,Ovarian Cancer,Tuberous Sclerosis 2,Breast Cancer,Parkinson Disease, Late-Onset,Colorectal Cancer,Hepatocellular Carcinoma,Septic Myocarditis,Pheochromocytoma,Ischemia,Skin Carcinoma,Chlamydia,Prostate Cancer,Disease Of Mental Health,Cholangiocarcinoma,Skin Disease,Retinoblastoma,Rheumatoid Arthritis,Inflammatory Bowel Disease,Trichothiodystrophy 5, Nonphotosensitive,Fibrodysplasia Ossificans Progressiva,Acute Promyelocytic Leukemia,Pulmonary Disease, Chronic Obstructive,Lipoprotein Quantitative Trait Locus,Cardiomyopathy, Familial Hypertrophic, 25,Alexander Disease,Lung Cancer,Osteogenic Sarcoma,Asthma |
2fst_x | Q16539 | ENSG00000112062 | MAPK14 | 99.60 | 1.60E-19 | 1.30E-23 | 180.20 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YHR030C | SLT2 | SGDID:S000001072 | CIPK23 LKS1 PKS17 SnRK3.23 At1g30270 F12P21.6 |
CBL-interacting serine/threonine-protein kinase 23 (EC 2.7.11.1) (Protein LOW-K(+)-SENSITIVE 1) (SNF1-related kinase 3.23) (SOS2-like protein kinase PKS17) |
2.7.11.1 | Arabidopsis thaliana | 4czt_d | Q93VD3 | 99.20 | 8.70E-16 | 6.90E-20 | 158.30 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | |||
YHR030C | SLT2 | SGDID:S000001072 | CHEK1 CHK1 |
Serine/threonine-protein kinase Chk1 (EC 2.7.11.1) (CHK1 checkpoint homolog) (Cell cycle checkpoint kinase) (Checkpoint kinase-1) |
2.7.11.1 | Homo sapiens | Tongue Carcinoma,Neuroblastoma,Leukemia, Acute Myeloid,Sporadic Breast Cancer,Cerebellar Disease,Ovarian Cancer,Breast Cancer,Colorectal Cancer,Microcephaly,Xeroderma Pigmentosum, Variant Type,Fanconi Anemia, Complementation Group A,Retinoblastoma,Esophageal Cancer,Seckel Syndrome,Mantle Cell Lymphoma,Pigmentary Disorder, Reticulate, With Systemic Manifestations, X-Linked,Ovarian Clear Cell Carcinoma,Autosomal Recessive Cerebellar Ataxia,Li-Fraumeni Syndrome,Ataxia-Telangiectasia,Medulloblastoma,Primary Autosomal Recessive Microcephaly,Lung Cancer |
2e9v_b | O14757 | ENSG00000149554 | CHEK1 | 99.30 | 3.60E-16 | 3.00E-20 | 145.90 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YHR030C | SLT2 | SGDID:S000001072 | PHO85 SSG3 YPL031C P7102.18A |
Cyclin-dependent protein kinase PHO85 (EC 2.7.11.22) (Negative regulator of the PHO system) (Serine/threonine-protein kinase PHO85) |
2.7.11.22 | Saccharomyces cerevisiae | 4krc_a | P17157 | 99.20 | 7.00E-16 | 5.80E-20 | 149.30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YHR030C | SLT2 | SGDID:S000001072 | CDK5 CDKN5 |
Cyclin-dependent-like kinase 5 (EC 2.7.11.1) (Cell division protein kinase 5) (Serine/threonine-protein kinase PSSALRE) (Tau protein kinase II catalytic subunit) (TPKII catalytic subunit) |
2.7.11.1 | Homo sapiens | Cerebellar Hypoplasia,Supranuclear Palsy, Progressive, 1,Polycystic Kidney Disease,Dyslexia,Alzheimer Disease,Amyotrophic Lateral Sclerosis 1,Transient Cerebral Ischemia,Giant Axonal Neuropathy 2,Motor Neuron Disease,Neuroblastoma,Hereditary Spastic Paraplegia,Nephronophthisis,Alzheimer Disease 9,Scrapie,Parkinson Disease, Late-Onset,Lissencephaly With Cerebellar Hypoplasia,Pick Disease Of Brain,Ischemia,Developmental And Epileptic Encephalopathy 5,Disease Of Mental Health,Toxic Encephalopathy,Dementia, Lewy Body,Lissencephaly,Aneurysmal Bone Cysts,Lissencephaly 7 With Cerebellar Hypoplasia,Syndromic Intellectual Disability,Non-Syndromic Intellectual Disability,Multiple System Atrophy 1,Myasthenic Syndrome, Congenital, 19,Primary Autosomal Recessive Microcephaly,C Syndrome,Lung Cancer |
4au8_b | Q00535 | ENSG00000164885 | CDK5 | 99.30 | 7.20E-17 | 6.10E-21 | 153.30 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YHR030C | SLT2 | SGDID:S000001072 | cgd5_2510 |
cgd5_2510 |
Cryptosporidium parvum | 3niz_a | Q5CRJ8 | 99.40 | 4.90E-17 | 4.00E-21 | 157.40 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YHR030C | SLT2 | SGDID:S000001072 | cgd2_1960 |
cgd2_1960 |
2.7.11.24 | Cryptosporidium parvum | 3oz6_a | A3FQ79 | 99.50 | 8.90E-19 | 7.30E-23 | 175.10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YHR030C | SLT2 | SGDID:S000001072 | PAK4 KIAA1142 |
Serine/threonine-protein kinase PAK 4 (EC 2.7.11.1) (p21-activated kinase 4) (PAK-4) |
2.7.11.1 | Homo sapiens | Polycystic Kidney Disease 3 With Or Without Polycystic Liver Disease |
4xbr_a | O96013 | ENSG00000130669 | PAK4 | 99.30 | 6.50E-16 | 5.30E-20 | 153.20 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YHR030C | SLT2 | SGDID:S000001072 | MAPK8 JNK1 PRKM8 SAPK1 SAPK1C |
Mitogen-activated protein kinase 8 (MAP kinase 8) (MAPK 8) (EC 2.7.11.24) (JNK-46) (Stress-activated protein kinase 1c) (SAPK1c) (Stress-activated protein kinase JNK1) (c-Jun N-terminal kinase 1) |
2.7.11.24 | Homo sapiens | Liver Disease,Endometrial Cancer,Lung Cancer Susceptibility 3,Non-Alcoholic Fatty Liver Disease,Hepatitis C,Acantholytic Acanthoma,Leukemia, Chronic Myeloid,Diabetes Mellitus,Non-Alcoholic Steatohepatitis,Fatty Liver Disease,Alzheimer Disease,Epidermolysis Bullosa Simplex,Hepatitis,Colon Adenocarcinoma,Neuroblastoma,Cervical Non-Keratinizing Squamous Cell Carcinoma,Hereditary Spastic Paraplegia,Leukemia, Acute Lymphoblastic,Ovarian Cancer,Burkitt Lymphoma,Breast Cancer,Glioblastoma,Parkinson Disease, Late-Onset,Colorectal Cancer,Hepatocellular Carcinoma,Sarcoma,Fibrosarcoma,Skin Carcinoma,Gastric Cancer,Breast Adenocarcinoma,Prostate Cancer,Disease Of Mental Health,Rheumatoid Arthritis,Type 2 Diabetes Mellitus,Renal Fibrosis,Acute Promyelocytic Leukemia,Huntington Disease,Nasopharyngeal Carcinoma,Cardiomyopathy, Familial Hypertrophic, 25,Neu-Laxova Syndrome 1,Lung Cancer,Pancreatic Cancer |
2xrw_a | P45983 | ENSG00000107643 | MAPK8 | 99.50 | 4.40E-19 | 3.60E-23 | 176.90 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YHR030C | SLT2 | SGDID:S000001072 | MELK KIAA0175 |
Maternal embryonic leucine zipper kinase (hMELK) (EC 2.7.11.1) (Protein kinase Eg3) (pEg3 kinase) (Protein kinase PK38) (hPK38) (Tyrosine-protein kinase MELK) (EC 2.7.10.2) |
2.7.10.2 | Homo sapiens | Colorectal Cancer |
5k00_a | Q14680 | ENSG00000165304 | MELK | 99.30 | 3.60E-16 | 3.00E-20 | 153.20 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YHR030C | SLT2 | SGDID:S000001072 | DYRK2 |
Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1) |
2.7.12.1 | Homo sapiens | 4azf_a | Q92630 | ENSG00000127334 | DYRK2 | 99.40 | 4.90E-17 | 3.90E-21 | 164.80 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YHR030C | SLT2 | SGDID:S000001072 | ROP5B ROP5 TGRH88_057710 |
ROP5B ROP5 TGRH88_057710 |
Toxoplasma gondii | 4lv5_a | F2YGR7 | 99.20 | 8.80E-16 | 7.30E-20 | 152.30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YHR030C | SLT2 | SGDID:S000001072 | PHKG2 |
Phosphorylase b kinase gamma catalytic chain, liver/testis isoform (PHK-gamma-LT) (PHK-gamma-T) (EC 2.7.11.19) (PSK-C3) (Phosphorylase kinase subunit gamma-2) |
2.7.11.19 | Homo sapiens | Glycogen Storage Disease Ixa,Glycogen Storage Disease Ixc,Glycogen Storage Disease,Phosphorylase Kinase Deficiency,Glycogen Storage Disease Due To Liver Phosphorylase Kinase Deficiency,Glycogen Storage Disease Ia,Glycogen Storage Disease, Type Ixd,Glycogen Storage Disease Ix,Glycogen Storage Disease Ixb |
2y7j_c | P15735 | ENSG00000156873 | PHKG2 | 99.30 | 1.50E-16 | 1.20E-20 | 157.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YHR030C | SLT2 | SGDID:S000001072 | Mapk1 Erk2 Mapk Prkm1 |
Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2) |
2.7.11.24 | Rattus norvegicus | 4xne_a | P63086 | 99.50 | 2.90E-18 | 2.40E-22 | 168.90 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YHR030C | SLT2 | SGDID:S000001072 | GSK3 LMJF_18_0270 |
GSK3 LMJF_18_0270 |
2.7.11.1 | Leishmania major | 3e3p_a | Q4QE15 | 99.30 | 3.00E-16 | 2.50E-20 | 154.90 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YHR030C | SLT2 | SGDID:S000001072 | ssp2 SPCC74.03c |
SNF1-like protein kinase ssp2 (EC 2.7.11.1) |
2.7.11.1 | Schizosaccharomyces pombe | 3h4j_b | O74536 | 99.20 | 1.10E-15 | 8.80E-20 | 149.50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YHR030C | SLT2 | SGDID:S000001072 | MAPK1 ERK2 PRKM1 PRKM2 |
Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2) |
2.7.11.24 | Homo sapiens | Pancreatic Adenocarcinoma,Heart Disease,Learning Disability,Endometrial Cancer,Autosomal Dominant Polycystic Kidney Disease,Differentiating Neuroblastoma,Squamous Cell Carcinoma,Vascular Disease,Lung Cancer Susceptibility 3,Spinal Cord Injury,Polycystic Kidney Disease,Melanoma,Leukemia, Chronic Myeloid,Thyroid Gland Anaplastic Carcinoma,Diabetes Mellitus,Noonan Syndrome 13,Alzheimer Disease,Rasopathy,Retrograde Amnesia,Bile Duct Cancer,Specific Learning Disability,Human Cytomegalovirus Infection,Hepatitis,Mesangial Proliferative Glomerulonephritis,Insulin-Like Growth Factor I,Neuroblastoma,Angioimmunoblastic T-Cell Lymphoma,Glioma,Noonan Syndrome 1,Dilated Cardiomyopathy,Bladder Cancer,Lung Adenoma,Pediculus Humanus Corporis Infestation,Cystic Kidney Disease,Ovarian Cancer,Myeloid Leukemia,Burkitt Lymphoma,Tuberous Sclerosis,Breast Cancer,Glioblastoma,Squamous Cell Carcinoma, Head And Neck,Microphthalmia,Colorectal Cancer,Hepatocellular Carcinoma,Cardiofaciocutaneous Syndrome 1,Microcephaly,Opioid Addiction,Pheochromocytoma,Rhabdomyosarcoma,Hepatitis C Virus,Alacrima, Achalasia, And Mental Retardation Syndrome,Mood Disorder,Esophagus Sarcoma,Sarcoma,Anhidrosis,Pertussis,Fibrosarcoma,Skin Carcinoma,Gastric Cancer,Breast Adenocarcinoma,Prostate Cancer,Disease Of Mental Health,Cholangiocarcinoma,Cervical Cancer,Bladder Squamous Cell Carcinoma,Fragile X Syndrome,Bladder Urothelial Carcinoma,Esophageal Cancer,Muscle Hypertrophy,Fibrodysplasia Ossificans Progressiva,Chromosome 22q11.2 Deletion Syndrome, Distal,Ewing Sarcoma,Heart, Malformation Of,Acute Promyelocytic Leukemia,Kaposi Sarcoma,Cardiomyopathy, Familial Hypertrophic, 25,Lung Cancer,Gordon Holmes Syndrome,Pancreatic Cancer |
4zzn_a | P28482 | ENSG00000100030 | MAPK1 | 99.50 | 4.10E-19 | 3.40E-23 | 174.90 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YHR030C | SLT2 | SGDID:S000001072 | CAMK2D CAMKD |
Calcium/calmodulin-dependent protein kinase type II subunit delta (CaM kinase II subunit delta) (CaMK-II subunit delta) (EC 2.7.11.17) |
2.7.11.17 | Homo sapiens | Dilated Cardiomyopathy,Cardiomyopathy, Dilated, 1dd |
2vn9_a | Q13557 | ENSG00000145349 | CAMK2D | 99.20 | 1.40E-15 | 1.10E-19 | 145.90 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YHR030C | SLT2 | SGDID:S000001072 | CDKL3 NKIAMRE |
Cyclin-dependent kinase-like 3 (EC 2.7.11.22) (Serine/threonine-protein kinase NKIAMRE) |
2.7.11.22 | Homo sapiens | Orofaciodigital Syndrome Vi |
3zdu_a | Q8IVW4 | ENSG00000006837 | CDKL3 | 99.30 | 4.70E-16 | 3.90E-20 | 151.10 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YHR030C | SLT2 | SGDID:S000001072 | LDBPK_331470 |
LDBPK_331470 |
Leishmania donovani | 4qny_a | E9BQ78 | 99.50 | 5.40E-19 | 4.50E-23 | 174.40 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YHR030C | SLT2 | SGDID:S000001072 | PIM1 |
Serine/threonine-protein kinase pim-1 (EC 2.7.11.1) |
2.7.11.1 | Homo sapiens | Retinitis Pigmentosa,Polyploidy,Plasma Protein Metabolism Disease,Primary Central Nervous System Lymphoma,Diamond-Blackfan Anemia,Myeloid Leukemia,Prostate Cancer,Mantle Cell Lymphoma |
3f2a_a | P11309 | ENSG00000137193 | PIM1 | 99.20 | 1.70E-15 | 1.40E-19 | 144.40 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YHR030C | SLT2 | SGDID:S000001072 | MAPK10 JNK3 JNK3A PRKM10 SAPK1B |
Mitogen-activated protein kinase 10 (MAP kinase 10) (MAPK 10) (EC 2.7.11.24) (MAP kinase p49 3F12) (Stress-activated protein kinase 1b) (SAPK1b) (Stress-activated protein kinase JNK3) (c-Jun N-terminal kinase 3) |
2.7.11.24 | Homo sapiens | Cryptococcal Meningitis,Diabetes Mellitus,Alzheimer Disease,Amyotrophic Lateral Sclerosis 1,Cataract,Breast Cancer,Parkinson Disease, Late-Onset,Human Immunodeficiency Virus Type 1,Pheochromocytoma,Pertussis,Opioid Abuse,Type 2 Diabetes Mellitus,Lennox-Gastaut Syndrome,Huntington Disease,Pancreatic Cancer |
3oy1_a | P53779 | ENSG00000109339 | MAPK10 | 99.40 | 3.60E-17 | 2.90E-21 | 162.00 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YHR030C | SLT2 | SGDID:S000001072 | MPK6 At2g43790 F18O19.10 |
Mitogen-activated protein kinase 6 (AtMPK6) (MAP kinase 6) (EC 2.7.11.24) |
2.7.11.24 | Arabidopsis thaliana | 6dtl_a | Q39026 | 99.50 | 1.00E-18 | 8.40E-23 | 173.80 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |